AB Science, Paris (ABSCF, $0.8) was a top loser over the last three months, falling -7 to $0.8 per share. A.I.dvisor analyzed 225 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending December 24, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.